The rating assignment was based on a number of factors, such as the system’s healthy and growing absolute cash position and solid operating profile. In fiscal year 2014, SLUHN had a 2.2 percent operating margin and a 10.7 percent operating cash flow margin.
The system also faces some challenges, which were considered for the rating assignment, including having a sizable amount of indirect debt.
SLUHN’s outlook is currently stable, which reflects Moody’s expectation that it “will maintain margins that can support its higher debt level and at least maintain current balance sheet ratios.”
More articles on healthcare finance:
How Oregon’s Medicaid system continues to bend the cost curve
Carolinas HealthCare presses on in fight over new hospital in South Carolina
4 hospitals receive credit downgrades in past month
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
